APOE and Stroke: HRT has also been shown to slow telomeric shortening in APOE carriers [147]; furthermore, evidence from Rippon et al. [34] shows clear support for an association between HRT use and an 11-fold increase in AD diagnosis in women who were APOE ε4-positive with previous history of stroke.